|
GLG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.102500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.755900E-02 |
| Normal-vs-Stage2 |
9.300400E-02 |
| Normal-vs-Stage3 |
5.195800E-01 |
| Normal-vs-Stage4 |
2.18299999998894E-06 |
| Stage1-vs-Stage2 |
8.103000E-01 |
| Stage1-vs-Stage3 |
6.807200E-01 |
| Stage1-vs-Stage4 |
3.918900E-03 |
| Stage2-vs-Stage3 |
6.025400E-01 |
| Stage2-vs-Stage4 |
2.694400E-02 |
| Stage3-vs-Stage4 |
1.539500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.635980E-01 |
| Normal-vs-AfricanAmerican |
2.175900E-02 |
| Normal-vs-Asian |
2.747600E-01 |
| Caucasian-vs-AfricanAmerican |
2.492000E-01 |
| Caucasian-vs-Asian |
4.281200E-01 |
| AfricanAmerican-vs-Asian |
5.479600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.983600E-03 |
| Normal-vs-Female |
3.945800E-01 |
| Male-vs-Female |
4.216800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.287850E-02 |
| Normal-vs-Extreme_Weight |
2.211700E-02 |
| Normal-vs-Obese |
8.183000E-01 |
| Normal-vs-Extreme_Obese |
2.029500E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.782400E-01 |
| Normal_Weight-vs-Obese |
8.621800E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.218400E-01 |
| Extreme_Weight-vs-Obese |
1.338840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.770600E-01 |
| Obese-vs-Extreme_Obese |
2.922800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.884800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.410400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.039590E-02 |
| Normal-vs-Age(81-100Yrs) |
1.537170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.695000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.916000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.101000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.880300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.187000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.341200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.991400E-01 |
| Normal-VS-Type2 PRCC |
1.366940E-04 |
| Normal-VS-KIRP CIMP |
4.471200E-01 |
| Normal-VS-Unclassified PRCC |
4.374800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.180600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.688600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.140200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.092000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.539300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.433200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.944400E-03 |
| Normal-vs-N1 |
9.959600E-02 |
| Normal-vs-N2 |
3.591800E-02 |
| N0-vs-N1 |
5.790600E-01 |
| N0-vs-N2 |
8.059000E-01 |
| N1-vs-N2 |
5.811200E-01 |
|
|
